215 related articles for article (PubMed ID: 23707302)
41. Alteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency.
Jiang D; Zhang Y; Hart RP; Chen J; Herrup K; Li J
Brain; 2015 Dec; 138(Pt 12):3520-36. PubMed ID: 26510954
[TBL] [Abstract][Full Text] [Related]
42. Rotavirus activates a noncanonical ATM-Chk2 branch of DNA damage response during infection to positively regulate viroplasm dynamics.
Sarkar R; Patra U; Lo M; Mukherjee A; Biswas A; Chawla-Sarkar M
Cell Microbiol; 2020 Mar; 22(3):e13149. PubMed ID: 31845505
[TBL] [Abstract][Full Text] [Related]
43. Studying the cerebellar DNA damage response in the tissue culture dish.
Tzur-Gilat A; Ziv Y; Mittelman L; Barzilai A; Shiloh Y
Mech Ageing Dev; 2013 Oct; 134(10):496-505. PubMed ID: 23583690
[TBL] [Abstract][Full Text] [Related]
44. The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle.
Biton S; Barzilai A; Shiloh Y
DNA Repair (Amst); 2008 Jul; 7(7):1028-38. PubMed ID: 18456574
[TBL] [Abstract][Full Text] [Related]
45. Genetic ataxia telangiectasia porcine model phenocopies the multisystemic features of the human disease.
Beraldi R; Meyerholz DK; Savinov A; Kovács AD; Weimer JM; Dykstra JA; Geraets RD; Pearce DA
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2862-2870. PubMed ID: 28746835
[TBL] [Abstract][Full Text] [Related]
46. Oxidative stress in ataxia telangiectasia.
Watters DJ
Redox Rep; 2003; 8(1):23-9. PubMed ID: 12631440
[TBL] [Abstract][Full Text] [Related]
47. Evidence for the Deregulation of Protein Turnover Pathways in Atm-Deficient Mouse Cerebellum: An Organotypic Study.
Kim CD; Reed RE; Juncker MA; Fang Z; Desai SD
J Neuropathol Exp Neurol; 2017 Jul; 76(7):578-584. PubMed ID: 28535250
[TBL] [Abstract][Full Text] [Related]
48. Elevated inflammatory responses and targeted therapeutic intervention in a preclinical mouse model of ataxia-telangiectasia lung disease.
Saunders RA; Michniacki TF; Hames C; Moale HA; Wilke C; Kuo ME; Nguyen J; Hartlerode AJ; Moore BB; Sekiguchi JM
Sci Rep; 2021 Feb; 11(1):4268. PubMed ID: 33608602
[TBL] [Abstract][Full Text] [Related]
49. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.
Shull ER; Lee Y; Nakane H; Stracker TH; Zhao J; Russell HR; Petrini JH; McKinnon PJ
Genes Dev; 2009 Jan; 23(2):171-80. PubMed ID: 19171781
[TBL] [Abstract][Full Text] [Related]
50. The role of the DNA damage response kinase ataxia telangiectasia mutated in neuroprotection.
Marinoglou K
Yale J Biol Med; 2012 Dec; 85(4):469-80. PubMed ID: 23239948
[TBL] [Abstract][Full Text] [Related]
51. Genome-Wide Screening in Human Embryonic Stem Cells Highlights the Hippo Signaling Pathway as Granting Synthetic Viability in ATM Deficiency.
Viner-Breuer R; Golan-Lev T; Benvenisty N; Goldberg M
Cells; 2023 May; 12(11):. PubMed ID: 37296624
[No Abstract] [Full Text] [Related]
52. ATM modulates subventricular zone neural stem cell maintenance and senescence through Notch signaling pathway.
Dong C; Wang X; Sun L; Zhu L; Yang D; Gao S; Zhang W; Ling B; Liang A; Gao Z; Xu J
Stem Cell Res; 2022 Jan; 58():102618. PubMed ID: 34915311
[TBL] [Abstract][Full Text] [Related]
53. New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease.
Ricci A; Biancucci F; Morganti G; Magnani M; Menotta M
Cell Mol Life Sci; 2022 Nov; 79(12):601. PubMed ID: 36422718
[TBL] [Abstract][Full Text] [Related]
54. Modulation of proteostasis counteracts oxidative stress and affects DNA base excision repair capacity in ATM-deficient cells.
Poletto M; Yang D; Fletcher SC; Vendrell I; Fischer R; Legrand AJ; Dianov GL
Nucleic Acids Res; 2017 Sep; 45(17):10042-10055. PubMed ID: 28973444
[TBL] [Abstract][Full Text] [Related]
55. A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease.
Beraldi R; Chan CH; Rogers CS; Kovács AD; Meyerholz DK; Trantzas C; Lambertz AM; Darbro BW; Weber KL; White KA; Rheeden RV; Kruer MC; Dacken BA; Wang XJ; Davis BT; Rohret JA; Struzynski JT; Rohret FA; Weimer JM; Pearce DA
Hum Mol Genet; 2015 Nov; 24(22):6473-84. PubMed ID: 26374845
[TBL] [Abstract][Full Text] [Related]
56. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
Lavin MF; Khanna KK
Int J Radiat Biol; 1999 Oct; 75(10):1201-14. PubMed ID: 10549596
[TBL] [Abstract][Full Text] [Related]
57. Ataxia-telangiectasia-mutated-dependent activation of Ku in human fibroblasts exposed to hydrogen peroxide.
Lee JH; Kim KH; Morio T; Kim H
Ann N Y Acad Sci; 2006 Dec; 1091():76-82. PubMed ID: 17341604
[TBL] [Abstract][Full Text] [Related]
58. Sensors and Inhibitors for the Detection of Ataxia Telangiectasia Mutated (ATM) Protein Kinase.
Huang C; Filippone NR; Reiner T; Roberts S
Mol Pharm; 2021 Jul; 18(7):2470-2481. PubMed ID: 34125542
[TBL] [Abstract][Full Text] [Related]
59. Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1.
Balmus G; Zhu M; Mukherjee S; Lyndaker AM; Hume KR; Lee J; Riccio ML; Reeves AP; Sutter NB; Noden DM; Peters RM; Weiss RS
Hum Mol Genet; 2012 Aug; 21(15):3408-20. PubMed ID: 22575700
[TBL] [Abstract][Full Text] [Related]
60. GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells.
Pintado-Berninches L; Fernandez-Varas B; Benitez-Buelga C; Manguan-Garcia C; Serrano-Benitez A; Iarriccio L; Carrillo J; Guenechea G; Egusquiaguirre SP; Pedraz JL; Hernández RM; Igartua M; Arias-Salgado EG; Cortés-Ledesma F; Sastre L; Perona R
Cell Death Differ; 2019 Oct; 26(10):1998-2014. PubMed ID: 30670828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
